Potential use of glioblastoma tumorsphere: Clinical credentialing

Seok Gu Kang, Jae Ho Cheong, Yong Min Huh, Eui Hyun Kim, Sun Ho Kim, Jong Hee Chang

Research output: Contribution to journalReview articlepeer-review

22 Citations (Scopus)


A decade ago, cancer stem cells (CSCs) were introduced as target cells for an innovative cancer treatment. Particularly, there have been a lot of biological researches on glioblastoma (GBM) CSCs. However, as there is a comprehensive change in the concept of CSCs, it is required to review how the different CSCs for patients can be clinically used, or clinical credentialing, and summarize the possibilities of clinical credentialing. In this regard, this review aims to introduce the tumorsphere obtained from GBM specimen and summarize the clinical dilemma and clinically applicable areas.

Original languageEnglish
Pages (from-to)402-407
Number of pages6
JournalArchives of pharmacal research
Issue number3
Publication statusPublished - 2015 Mar

Bibliographical note

Publisher Copyright:
© 2015 The Pharmaceutical Society of Korea.

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery
  • Organic Chemistry


Dive into the research topics of 'Potential use of glioblastoma tumorsphere: Clinical credentialing'. Together they form a unique fingerprint.

Cite this